Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -141.43% is 28% above its 5-year average of -196.44%, near the high end of its 5-year range (-907.48%–70.05%).
56.00% above its 12-month average of -321.41%.
Reported quarterly profit margin; no daily interpolation.
NET PROFIT MARGIN
-141.43%
NET PROFIT MARGIN AVG TTM
-321.41%
NET PROFIT MARGIN AVG 3Y
-346.54%
NET PROFIT MARGIN AVG 5Y
-196.44%
NET PROFIT MARGIN AVG 10Y
-261.93%
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
+56.00%
CURRENT VS 3Y AVG
+59.19%
CURRENT VS 5Y AVG
+28.00%
CURRENT VS 10Y AVG
+46.00%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
8.98%
median of 90 covered companies
CURRENT VS SECTOR MEDIAN
-1674.94%
vs the sector median at left
Moderna, Inc.
Market Cap
$55.68B
Net Profit Margin
-141.43%
TTM Avg
-321.41%
3Y Avg
-346.54%
5Y Avg
-196.44%
Market Cap
$56.32B
Net Profit Margin
0.67%
TTM Avg
0.69%
3Y Avg
0.48%
5Y Avg
0.29%
Market Cap
$49.93B
Net Profit Margin
15.43%
TTM Avg
47.22%
3Y Avg
37.68%
5Y Avg
33.03%
Market Cap
$49.35B
Net Profit Margin
4.52%
TTM Avg
8.06%
3Y Avg
8.30%
5Y Avg
8.27%
Market Cap
$66.86B
Net Profit Margin
17.47%
TTM Avg
12.73%
3Y Avg
10.54%
5Y Avg
8.34%
Market Cap
$42.81B
Net Profit Margin
4.08%
TTM Avg
-0.87%
3Y Avg
-5.42%
5Y Avg
-7.16%
Market Cap
$42.67B
Net Profit Margin
8.10%
TTM Avg
8.63%
3Y Avg
8.47%
5Y Avg
7.22%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Moderna, Inc. (MRNA) | $55.68B | -141.43% | -321.41% | -346.54% | -196.44% |
| Cardinal Health, Inc. (CAH)vs › | $56.32B | 0.67% | 0.69% | 0.48% | 0.29% |
| Edwards Lifesciences Corporation (EW)vs › | $49.93B | 15.43% | 47.22% | 37.68% | 33.03% |
| Becton, Dickinson and Company (BDX)vs › | $49.35B | 4.52% | 8.06% | 8.30% | 8.27% |
| Humana Inc. (HUM)vs › | $48.40B | 0.88% | 0.97% | 1.82% | 2.53% |
| Cencora, Inc. (COR)vs › | $63.17B | 0.79% | 0.49% | 0.59% | 0.22% |
| Boston Scientific Corporation (BSX)vs › | $66.86B | 17.47% | 12.73% | 10.54% | 8.34% |
| Teva Pharmaceutical Industries Limited (TEVA)vs › | $42.81B | 4.08% | -0.87% | -5.42% | -7.16% |
| IQVIA Holdings Inc. (IQV)vs › | $42.67B | 8.10% | 8.63% | 8.47% | 7.22% |
| Agilent Technologies, Inc. (A)vs › | $41.48B | 19.53% | 19.27% | 18.75% | 17.94% |
Operating Margin
-158.1%
Net Profit Margin
-141.4%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -539.31% |
| 2026-03-31 | -345.24% |
| 2025-12-31 | -121.83% |
| 2025-09-30 | -19.69% |
| 2025-06-30 | -580.99% |
| 2025-03-31 | -907.48% |
| 2024-12-31 | -117.15% |
| 2024-09-30 | 0.70% |
| 2024-06-30 | -578.73% |
| 2024-03-31 | -703.59% |
| 2023-12-31 | 7.71% |
| 2023-09-30 | -198.25% |
| 2023-06-30 | -401.16% |
| 2023-03-31 | 4.30% |
| 2022-12-31 | 28.45% |
| 2022-09-30 | 32.39% |
| 2022-06-30 | 48.12% |
| 2022-03-31 | 61.57% |
| 2021-12-31 | 70.05% |
| 2021-09-30 | 69.02% |
| 2021-06-30 | 65.95% |
| 2021-03-31 | 70.05% |
| 2020-12-31 | -47.74% |
| 2020-09-30 | -147.96% |
| 2020-06-30 | -175.90% |
| 2020-03-31 | -1480.87% |
| 2019-12-31 | -877.20% |
| 2019-09-30 | -722.72% |
| 2019-06-30 | -1032.29% |
| 2019-03-31 | -827.31% |
| 2018-12-31 | -399.27% |
| 2018-09-30 | -192.38% |
| 2018-06-30 | -314.03% |
| 2018-03-31 | -249.24% |
| 2017-12-31 | -41.29% |
| 2017-09-30 | -160.72% |
| 2017-06-30 | -224.15% |
| 2017-03-31 | -224.15% |
